Discovery of novel dithiocarbamic acid ester HGWJ-11C with significant anticancer action

doi:10.5246/jcps.2014.10.087

Abstract

Abstract:

To find novel lead compound, seventy-four compound libraries were built through two rounds by a solution-phase CC on the basis of our developed method for the synthesis of dithiocarbamic acid ester. After evaluation for the antitumor activitiesof libraries, six compounds were selected to be synthesized and examined their antitumor activities. It was found that compound 13 (HGWJ-11C) with novel structure exhibited significant antitumor activities and the scaffold of dithiocarbamic acid was very crucial for the antitumor activity. The compound 13 is worth studying deeply as a potent hit compound.

Key words: Libraries, Solution-phase CC, Dithiocarbamic acid ester, Antitumor

CLC Number:

R916

Supporting:

Bin Liu, Jun Wei, Yiqiang Wang, Zemei Ge, Runtao Li. Discovery of novel dithiocarbamic acid ester HGWJ-11C with significant anticancer action[J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(10): 681-687.

References

[1] (a) Takasugi, M.K.N.; Shiratab, A. J. Chem. Soc. Chem. Commun. 1986, 1077; (b) Pedras, M.S.; Jha, M. Bioorg. Med. Chem. 2006, 14, 4958-4979; (c) Csomos, P.; Zupko, I.; Rethy, B.; Fodor, L.; Falkay, G.; Bernath, G. Bioorg. Med. Chem. Lett. 2006, 16, 6273-6276.

[2] Gerhauser, C.Y.M.; Pezzuto, J.F. Cancer Res. 1997,52, 272-278.

[3] Zahran, M.A.; Salem, T.A.; Samaka, R.M.; Agwa, H.S.; Awad, A.R. Bioorg. Med. Chem. 2008, 16, 9708-9718.

[4] Huang, W.; Ding, Y.; Miao, Y.; Liu, M.Z.; Li, Y.; Yang, G.F. Eur. J. Med. Chem. 2009,44, 3687-3696.

[5] (a) Cao, S.L.; Feng, Y.P.; Jiang, Y.Y.; Liu, S.Y.; Ding, G.Y.; Li, R.T. Bioorg. Med. Chem. Lett. 2005,15, 1915-1917; (b) Cao, S.L.; Wang, Y.; Zhu, L.; Liao, J.; Guo, Y.W.; Chen, L.L.; Liu, H.Q.; Xu, X. Eur. J. Med. Chem. 2010,45, 3850-3857.

[6] Horita, Y.; Takii, T.; Kuroishi, R.; Chiba, T.; Ogawa, K.; Kremer, L.; Sato, Y.; Lee, Y.; Hasegawa, T.; Onozaki, K. Bioorg. Med. Chem. Lett. 2011,21, 899-903.

[7] (a) Scozzafava, A.S.; Supuran, C.T., Bioorg. Med. Chem. Lett. 2000,10, 1117-1120; (b) Scozzafava, A.M.A.; Supuran, C.T. Bioorg. Med. Chem. Lett. 2000,10, 1887-1891; (c) Carta, F.; Aggarwal, M.; Maresca, A.; Scozzafava, A.; McKenna, R.; Masini, E.; Supuran, C.T. J. Med. Chem. 2012,55, 1721-1730; (d) Marini, A.M.; Maresca, A.; Aggarwal, M.; Orlandini, E.; Nencetti, S.; Da Settimo, F.; Salerno, S.; Simorini, F.; La Motta, C.; Taliani, S.; Nuti, E.; Scozzafava, A.; McKenna, R.; Rossello, A.; Supuran, C.T. J. Med. Chem. 2012,55, 9619-9629; (e) Carta, F.; Akdemir, A.; Scozzafava, A.; Masini, E.; Supuran, C.T. J. Med. Chem. 2013,56, 4691-4700.

[8] Zheng, Y.C.; Duan, Y.C.; Ma, J.L.; Xu, R.M.; Zi, X.; Lv, W.L.; Wang, M.M.; Ye, X.W.; Zhu, S.; Mobley, D.; Zhu, Y.Y.; Wang, J.W.; Li, J.F.; Wang, Z.R.; Zhao, W.; Liu, H.M. J. Med. Chem. 2013, 56, 8543-8560.

[9] Hou, X.; Ge, Z.; Wang, T.; Guo, W.; Wu, J.; Cui, J.; Lai, C.; Li, R. Arch. Pharm. Chem. Life. Sci. 2011,344, 320-332.

[10] (a) Gallop, M.A.B.R.W.; Dower, W.J.; Fodor, S.P.A.; Gordon, E.M., 1994, 37, 1233-1251; (b) Gordon, E.M.B.R.W.; Dower, W.J.; Fodor, S.P.A.; Gallop, M.A., J. Med. Chem. 1994,10, 1385-1401; (c) Williard, X.P.I.; Bowel, L.; Horvath, D.; Baudelle, R.; Melnyk, P.; Deprez, B.; Tartar, A. Eur. J. Med. Chem. 1996,31, 87-98; (d) Puig-de-la-Bellacasa, R.; Gimenez, L.; Pettersson, S.; Pascual, R.; Gonzalo, E.; Este, J.A.; Clotet, B.; Borrell, J.I.; Teixido, J. Eur. J. Med. Chem. 2012,54, 159-174.

[11] (a) Cui, J.L.; Ge, Z.M.; Cheng, T.M.; Li, R.T. Synth. Commun. 2003,33, 1969-1976; (b) Guo, B.G.G.Z.M.; Cheng, T.M.; Li, R.T. Synth. Commun. 2001,31, 3021-3025.

[12] Boehm, M.; Wu, T.Y.; Claussen, H.; Lemmen, C. J. Med. Chem. 2008,51, 2468-2480.

[1]	Shiqi Xu, Liyan Zhu, Chao Hao, Wenqian Liu, Chenglong Chen, Yongyi Chen, Aiqin Liu. Synthesis of a novel series of amino acid prodrugs based on tegafur and evaluation of their antitumor activity [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(9): 743-753.
[2]	Zixiang Wang, Yifan Zhang, Wangchun Du, Qunli Chen, Hong Yao, Mei Zhao. Recent progress of natural products in tumor prevention and treatment by regulating the reactive oxygen species level [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(6): 455-467.
[3]	Beidou Zhou, Zihan Yu, Yugui Tong, Jiali Li, Baocheng Huang, Rongrong Wei, Zhimin Weng, Xin Wang, Zhipeng Ruan, Jian Lin, Caihong Xu, Jianbo Liu. Synthesis of prenylated and geranylated xanthones and their bioactivities [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(8): 564-576.
[4]	Beidou Zhou, Xin Wang, Zhimin Weng, Baocheng Huang, Zetong Ma, Bo Yu, Liqin Ruan, Dongbao Hu. Synthesis and antitumor, antityrosinase, and antiplatelet aggregation activities of xanthone [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(4): 247-256.
[5]	Yanli Hao, Ting Zhong, Ruo Du, Hua Zhang, Bilin Liu, Xuan Zhang. The cellular uptake and anti-tumor activity of conjugated linoleic acid-paclitaxel-loaded iRGD-modified lysolipid-containing thermosensitive liposomes [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(2): 121-133.
[6]	Xiaoxia Liang, Lingxi Kong, Min He. A new homoisoflavone compound as a potent antibacterial agent from Aspidistra typica Baill. [J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(9): 700-703.
[7]	Ting Sun, Xia Yuan, Wei Huang, Wei Guo, Zemei Ge, Runtao Li, Jingrong Cui . Effects and mechanism of proteasome inhibitor YSY01-A alone or in combination with cisplatin against A549 cells in vitro [J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(9): 607-616.
[8]	Jiesi Li, KeYang, Xiyu Ke, Ruo Du, Xuan Zhang*, Qiang Zhang. In vitro and in vivo antitumor efficacy of CLA-PTX on B16-F10 melanoma cells [J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(1): 46-53.
[9]	Xiaoyun Zhang^*, Hua Qiao, Peng Zhao, Jingman Ni, Yanbin Shi. Antitumor activity and biodistribution of DHA-NLC formulation in sarcoma 180-bearing mice [J]. , 2013, 22(4): 348-354.
[10]	Fei Peng, Pengchao Gao, Xiangtao Wang, Xin Hu^*. Acid sensitive doxorubicin-PAMAM with tumor targeting profile [J]. , 2013, 22(1): 81-88.
[11]	Ye-Huan Li, Guo-Zhou Zhang, Rong-Hua Huang, Dong-Dong Li, Yu Luo, Yong Yang, Yin-Qun Wu, Li-Hui Liu, Hui-Hui Zeng^*. Study on tissue distribution of a novel organoselenium antitumor compound WBSELEN [J]. , 2011, 20(6): 578-583.
[12]	Gong Li, Qi Sun, Jing-Rong Cui, Run-Tao Li^. Modification of the alkylating agent chlorambucil with spiropiperazinium salts [J]. , 2010, 19(5): 346-352.
[13]	Jia-Ning Fu, Jing-Yu Wang, Li-Hui Wang, Lei Wang, Wan-Chen Tang, Gao-Xiong Cai, Mi Liu, Hui-Hui Zeng^* . Drug efficacy and pharmacological action of an organoselenium compound ethaselen, a novel antitumor drug [J]. , 2010, 19(3): 163-168.
[14]	Min-Jun Huang, Zhen-Jun Yang, Liang-Ren Zhang^*, Li-He Zhang . Design and synthesis of L-5'-noraristeromycin analogues as potent antitumor agents [J]. , 2009, 18(4): 313-319.
[15]	Song Zhuang, Xian-Rong Qi^*. Antitumor efficacy of doxorubicin encapsulated in neovasculature targeting liposomes [J]. , 2009, 18(3): 257-260.